| Patient | Bruce Lee |
|---|---|
| Date of birth | 1940-11-27 |
| Identifiers | MRN HR-ML044-SYN-TD; SSN (made up) 000-44-6102 |
| Document date | 2026-11-01 |
| Author | Winston Cheung-Hartley, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Urgent follow-up four days after an emergency visit for a first convulsive collapse: history from him and a witness, triggers, examination, ECG, laboratory tests, driving and seizure safety, cannabis counseling, chronic back pain, and urgent epilepsy referral. Concerns: He wants to know what happened and whether it will happen again, and to keep training and making films; He does not want a daily medicine unless it is clearly needed, and wants to understand the evidence and decide for himself; His back pain must not stop him training. [S]
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Acetaminophen 500 mg oral tablet, one or two tablets up to three times a day when needed for back pain, no more than 3,000 mg a day | One or two tablets up to three times a day as needed; at most 3,000 mg a day | Oral route | 1973-05-14 | active | S |
| Naproxen 500 mg oral tablet, one tablet twice a day with food for seven days | One tablet twice a day with food for seven days | Oral route | 1973-06-22 to 1973-06-29 | completed | S |
| Procedure | Dates | Status | Evidence |
|---|---|---|---|
| Twelve-lead electrocardiogram in the clinic: sinus bradycardia at 56 per minute, normal PR and QRS intervals, QTc 412 ms, no pre-excitation, Brugada pattern or signs of cardiomyopathy | 1973-05-14 to 1973-05-14 | completed | S |
| Advance care planning conversation, about 15 minutes, with his consent | 1973-06-29 to 1973-06-29 | completed | S |
| MRI of the brain with an epilepsy protocol (thin coronal slices through the hippocampi, FLAIR and susceptibility sequences): normal; no hippocampal sclerosis, cortical malformation, tumor, scar, old hemorrhage or swelling | 1973-05-18 to 1973-05-18 | completed | S |
| Sleep-deprived electroencephalogram, about 60 minutes, with wakefulness, drowsiness and light sleep, hyperventilation and photic stimulation: normal background; no epileptiform discharges; no photoparoxysmal response | 1973-05-18 to 1973-05-18 | completed | S |
| Date | Vaccine | Status | Evidence |
|---|---|---|---|
| 1973-06-29 | Tetanus, diphtheria, and acellular pertussis vaccine (Tdap) | completed | S |
| 1973-06-29 | Hepatitis B vaccine (HepB-CpG), dose 1 of 2 | completed | S |
Historical biography with true dates. These events are not part of the synthetic care timeline.
| Historical date | History | Evidence |
|---|---|---|
| 1970 | Severe back injury lifting a 125-pound barbell without warming up, reported as an injury to the fourth sacral nerve; about six months of bed rest, then his own recovery program; chronic pain since | D (CLM-0005) |
| 1973 | Removal of the sweat glands from both armpits, months before the collapse, as reported by his biographer | D (CLM-0019) |
| Relative | Condition | Age at death | Evidence |
|---|---|---|---|
| father | Died in Hong Kong eight years ago; cause not recorded in the cited source | D (CLM-0020) |
| Concern | Status | Evidence |
|---|---|---|
| He wants to know what happened and whether it will happen again, and to keep training and making films | active | S |
| He does not want a daily medicine unless it is clearly needed, and wants to understand the evidence and decide for himself | active | S |
| His back pain must not stop him training | active | S |
Most recent measures: Sodium [Moles/volume] in Serum or Plasma 140 on 1973-06-15; Potassium [Moles/volume] in Serum or Plasma 4.3 on 1973-06-15; Creatinine [Mass/volume] in Serum or Plasma 0.96 on 1973-06-15; Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1968)/1.73 sq M 108 on 1973-06-15; Glucose [Mass/volume] in Serum or Plasma 90 on 1973-06-15; Chloride [Moles/volume] in Serum or Plasma 103 on 1973-05-14; Carbon dioxide, total [Moles/volume] in Serum or Plasma 25 on 1973-05-14; Calcium [Mass/volume] in Serum or Plasma 9.5 on 1973-05-14; Magnesium [Mass/volume] in Serum or Plasma 2 on 1973-05-14; Creatine kinase [Enzymatic activity/volume] in Serum or Plasma 168 on 1973-06-15; Leukocytes [#/volume] in Blood by Automated count 6.2 on 1973-05-14; Hemoglobin [Mass/volume] in Blood 14.6 on 1973-05-14; Platelets [#/volume] in Blood by Automated count 238 on 1973-05-14; Thyrotropin [Units/volume] in Serum or Plasma 1.6 on 1973-05-14; Q-T interval corrected 412 on 1973-05-14; Pain severity - 0-10 verbal numeric rating [Score] - Reported 2 on 1973-07-13; Total score [AUDIT-C] 1 on 1973-06-29; Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 0 on 1973-06-29 [S]
Strengths and supports: engagement in care [S]
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Sudden collapse with loss of consciousness four days before the visit, after hours of voice recording in a hot booth with the air conditioning off: felt hot and faint, lost consciousness, generalized stiffening then jerking of all four limbs for about a minute, vomiting, and 20 to 30 minutes of confusion; seizure versus convulsive syncope; emergency evaluation the same day | resolved | provisional | R55 | S — Synthetic presenting problem anchored to the documented collapse at the dubbing studio; resolved into a first seizure at the epilepsy clinic when the history, examination, ECG, MRI and EEG were reviewed together. Not a claim about his real symptoms beyond the cited accounts. |
| First unprovoked seizure: unknown-onset motor (tonic-clonic) seizure by the ILAE 1964 classification; MRI with epilepsy protocol and sleep-deprived EEG normal, so it does not meet the definition of epilepsy; likely triggers were sleep deprivation, heat, missed meals and cannabis the same day; no antiseizure medicine by shared decision; synthetic modern episode linked to his documented collapse with convulsions | active | confirmed | R56.9 | S — Synthetic modern diagnosis made at the epilepsy clinic; the 1973 events and their disputed causes remain D and R. |
| Chronic low back pain since a weightlifting injury three years ago, reported as an injury to a sacral nerve; worse with long sitting and heavy lifting; no weakness, numbness or bladder or bowel change | active | confirmed | M54.50 | S — Synthetic modern problem anchored to his documented back injury and chronic pain. |
| Acute flare of low back pain with left lumbar muscle spasm after twisting during a training kick; no red flags, normal saddle sensation and bladder function; resolved | resolved | confirmed | M62.830 | S — Synthetic intercurrent problem at an unscheduled visit; a flare of his documented chronic back pain, not a new historical diagnosis. |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 1973-05-14 | Sodium [Moles/volume] in Serum or Plasma | 139 | mmol/L | 135-145 mmol/L | Normal | S |
| 1973-05-14 | Potassium [Moles/volume] in Serum or Plasma | 4.1 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 1973-05-14 | Creatinine [Mass/volume] in Serum or Plasma | 1.02 | mg/dL | 0.74-1.35 mg/dL | Normal | S |
| 1973-05-14 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1968)/1.73 sq M | 100 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 1973-05-14 | Glucose [Mass/volume] in Serum or Plasma | 86 | mg/dL | 70-99 mg/dL | Normal | S |
| 1973-05-14 | Chloride [Moles/volume] in Serum or Plasma | 103 | mmol/L | 98-107 mmol/L | Normal | S |
| 1973-05-14 | Carbon dioxide, total [Moles/volume] in Serum or Plasma | 25 | mmol/L | 22-29 mmol/L | Normal | S |
| 1973-05-14 | Calcium [Mass/volume] in Serum or Plasma | 9.5 | mg/dL | 8.6-10.3 mg/dL | Normal | S |
| 1973-05-14 | Magnesium [Mass/volume] in Serum or Plasma | 2 | mg/dL | 1.7-2.2 mg/dL | Normal | S |
| 1973-05-14 | Creatine kinase [Enzymatic activity/volume] in Serum or Plasma | 820 | U/L | 39-308 U/L | High | S |
| 1973-05-14 | Leukocytes [#/volume] in Blood by Automated count | 6.2 | 10*3/uL | 3.4-9.6 10*3/uL | Normal | S |
| 1973-05-14 | Hemoglobin [Mass/volume] in Blood | 14.6 | g/dL | 13.2-16.6 g/dL | Normal | S |
| 1973-05-14 | Platelets [#/volume] in Blood by Automated count | 238 | 10*3/uL | 135-317 10*3/uL | Normal | S |
| 1973-05-14 | Thyrotropin [Units/volume] in Serum or Plasma | 1.6 | m[IU]/L | 0.4-4 mIU/L | Normal | S |
| 1973-05-14 | Q-T interval corrected | 412 | ms | 350-450 ms | Normal | S |
| 1973-05-14 | Pain severity - 0-10 verbal numeric rating [Score] - Reported | 4 | {score} | S | ||
| 1973-05-14 | Total score [AUDIT-C] | 1 | {score} | S | ||
| 1973-06-15 | Sodium [Moles/volume] in Serum or Plasma | 140 | mmol/L | 135-145 mmol/L | Normal | S |
| 1973-06-15 | Potassium [Moles/volume] in Serum or Plasma | 4.3 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 1973-06-15 | Creatinine [Mass/volume] in Serum or Plasma | 0.96 | mg/dL | 0.74-1.35 mg/dL | Normal | S |
| 1973-06-15 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1968)/1.73 sq M | 108 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 1973-06-15 | Glucose [Mass/volume] in Serum or Plasma | 90 | mg/dL | 70-99 mg/dL | Normal | S |
| 1973-06-15 | Creatine kinase [Enzymatic activity/volume] in Serum or Plasma | 168 | U/L | 39-308 U/L | Normal | S |
| 1973-06-15 | Pain severity - 0-10 verbal numeric rating [Score] - Reported | 3 | {score} | S | ||
| 1973-06-22 | Pain severity - 0-10 verbal numeric rating [Score] - Reported | 7 | {score} | S | ||
| 1973-07-13 | Pain severity - 0-10 verbal numeric rating [Score] - Reported | 2 | {score} | S | ||
| 1973-06-29 | Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] | 0 | {score} | S | ||
| 1973-06-29 | Total score [AUDIT-C] | 1 | {score} | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 1973-05-14 | Body height | 171 | cm | S |
| 1973-05-14 | Body weight | 57.6 | kg | S |
| 1973-05-14 | Body mass index (BMI) [Ratio] | 19.7 | kg/m2 | S |
| 1973-05-14 | Systolic blood pressure | 116 | mm[Hg] | S |
| 1973-05-14 | Diastolic blood pressure | 70 | mm[Hg] | S |
| 1973-05-14 | Heart rate | 58 | /min | S |
| 1973-05-14 | Respiratory rate | 14 | /min | S |
| 1973-05-14 | Body temperature | 36.7 | Cel | S |
| 1973-05-14 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| 1973-05-18 | Body height | 171 | cm | S |
| 1973-05-18 | Body weight | 57.8 | kg | S |
| 1973-05-18 | Body mass index (BMI) [Ratio] | 19.8 | kg/m2 | S |
| 1973-05-18 | Systolic blood pressure | 118 | mm[Hg] | S |
| 1973-05-18 | Diastolic blood pressure | 72 | mm[Hg] | S |
| 1973-05-18 | Heart rate | 60 | /min | S |
| 1973-05-18 | Respiratory rate | 14 | /min | S |
| 1973-05-18 | Body temperature | 36.6 | Cel | S |
| 1973-05-18 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| 1973-06-15 | Body height | 171 | cm | S |
| 1973-06-15 | Body weight | 58.6 | kg | S |
| 1973-06-15 | Body mass index (BMI) [Ratio] | 20 | kg/m2 | S |
| 1973-06-15 | Systolic blood pressure | 114 | mm[Hg] | S |
| 1973-06-15 | Diastolic blood pressure | 70 | mm[Hg] | S |
| 1973-06-15 | Heart rate | 56 | /min | S |
| 1973-06-15 | Respiratory rate | 14 | /min | S |
| 1973-06-15 | Body temperature | 36.6 | Cel | S |
| 1973-06-15 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| 1973-07-13 | Body height | 171 | cm | S |
| 1973-07-13 | Body weight | 59.4 | kg | S |
| 1973-07-13 | Body mass index (BMI) [Ratio] | 20.3 | kg/m2 | S |
| 1973-07-13 | Systolic blood pressure | 116 | mm[Hg] | S |
| 1973-07-13 | Diastolic blood pressure | 68 | mm[Hg] | S |
| 1973-07-13 | Heart rate | 56 | /min | S |
| 1973-07-13 | Respiratory rate | 14 | /min | S |
| 1973-07-13 | Body temperature | 36.5 | Cel | S |
| 1973-07-13 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| 1973-06-22 | Body height | 171 | cm | S |
| 1973-06-22 | Body weight | 58.8 | kg | S |
| 1973-06-22 | Body mass index (BMI) [Ratio] | 20.1 | kg/m2 | S |
| 1973-06-22 | Systolic blood pressure | 124 | mm[Hg] | S |
| 1973-06-22 | Diastolic blood pressure | 76 | mm[Hg] | S |
| 1973-06-22 | Heart rate | 66 | /min | S |
| 1973-06-22 | Respiratory rate | 16 | /min | S |
| 1973-06-22 | Body temperature | 36.7 | Cel | S |
| 1973-06-22 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| 1973-06-29 | Body height | 171 | cm | S |
| 1973-06-29 | Body weight | 59 | kg | S |
| 1973-06-29 | Body mass index (BMI) [Ratio] | 20.2 | kg/m2 | S |
| 1973-06-29 | Systolic blood pressure | 114 | mm[Hg] | S |
| 1973-06-29 | Diastolic blood pressure | 68 | mm[Hg] | S |
| 1973-06-29 | Heart rate | 56 | /min | S |
| 1973-06-29 | Respiratory rate | 14 | /min | S |
| 1973-06-29 | Body temperature | 36.6 | Cel | S |
| 1973-06-29 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| Date | Purpose | Status | Provenance |
|---|---|---|---|
| 1973-05-14 | Urgent follow-up four days after an emergency visit for a first convulsive collapse: history from him and a witness, triggers, examination, ECG, laboratory tests, driving and seizure safety, cannabis counseling, chronic back pain, and urgent epilepsy referral | finished | S |
| 1973-05-18 | Epilepsy clinic: MRI brain with epilepsy protocol, sleep-deprived EEG, classification, and the decision on an antiseizure medicine | finished | S |
| 1973-06-15 | One-month review: no further events, sleep and heat plan, kidney function and creatine kinase, back pain program | finished | S |
| 1973-07-13 | Two-month review: seizure-free, safety and driving, results of preventive tests, back pain and return to full training | finished | S |
| 1973-06-22 | Same-week sick visit for an acute flare of low back pain | finished | S |
| 1973-06-29 | Periodic adult preventive visit | finished | S |
| Intervention | Status | Guideline | Provenance |
|---|---|---|---|
| Culturally appropriate care: ask how he wishes to be addressed and in which language; explain the evidence plainly and let him decide; respect his own training methods and philosophy; share information with his family only as he chooses | completed | GL-AAN-SEIZURE-2015 | S |
| Urgent referral to the epilepsy clinic within the week, with MRI of the brain with an epilepsy protocol and a sleep-deprived EEG | completed | GL-AAN-EVAL-2007, GL-AAN-SEIZURE-2015 | S |
| Laboratory tests after the seizure: sodium, glucose, calcium, magnesium, kidney function, creatine kinase, blood count and TSH, with creatine kinase and creatinine repeated until normal | completed | GL-AAN-EVAL-2007 | S |
| No driving until the epilepsy clinic has seen him and the period without seizures it advises has passed; Hong Kong's driving licence regulations list epilepsy and liability to sudden fainting among the conditions for which the Commissioner for Transport must refuse or cancel a licence | completed | GL-HK-DL-374B, GL-DVLA-NEURO | S |
| Seizure safety: no swimming alone, no work at heights or with dangerous machinery, showers rather than baths, and seizure first aid taught to the people he works with; a stunt double for falls and heights until the clinic advises otherwise | completed | GL-CDC-SZFIRSTAID, GL-AAN-SEIZURE-2015 | S |
| Triggers: at least seven hours of sleep, regular meals, breaks and air conditioning during long recording and training sessions, and drinking to thirst with salty food or an electrolyte drink in the heat rather than large volumes of plain water | completed | GL-AAN-SEIZURE-2015 | S |
| Cannabis: a nonjudgmental conversation about cannabis, heat, sleep loss and seizures; he chose to stop while his risk is highest; no synthetic cannabinoids | completed | GL-AAN-SEIZURE-2015 | S |
| Medicine safety: avoid medicines that lower the seizure threshold, such as tramadol, bupropion and high doses of sedating antihistamines, and sedatives whose withdrawal can provoke seizures, such as meprobamate and carisoprodol; tell any doctor or pharmacist about the seizure | completed | GL-AAN-SEIZURE-2015, GL-ACP-LBP-2017 | S |
| Chronic back pain: a structured core strengthening and motor control program with a physical therapist, heat, and acetaminophen when needed; nonsteroidal anti-inflammatory drugs only in short courses, with food and normal fluids; no opioids | completed | GL-ACP-LBP-2017 | S |
| No antiseizure medicine after this first unprovoked seizure, by shared decision: his two-year recurrence risk is at the lower end of 21% to 45% with a normal MRI and EEG; immediate treatment would lower the two-year risk but not change long-term remission; a second unprovoked seizure would mean epilepsy and starting a medicine such as levetiracetam or lamotrigine | completed | GL-AAN-SEIZURE-2015, GL-ILAE-DEF-2014, GL-ILAE-SZ-2017 | S |
| Goal | Target | Status | Outcome | Provenance |
|---|---|---|---|---|
| No further seizures | 1973-07-13 | active | None in the two months since the first | S |
| Sleep at least seven hours a night, including on film schedules | 1973-06-15 | completed | About seven hours a night from the first month | S |
| No cannabis while the seizure risk is highest | 1973-07-13 | active | None since the seizure, by his report | S |
| Back pain at 3 or less out of 10 with full training | 1973-07-13 | completed | Pain 2 out of 10 after a flare that settled within a week | S |